Eric F. Bernstein earned a Bachelor of Science degree from Duke University in 1981 graduating Phi Beta Kappa, summa cum laude with distinction in his major. He then earned his degree in medicine from Yale University School of Medicine in 1986 where he served as Banner Bearer at commencement exercises and class president. Following his internship he completed a fellowship at the National Cancer Institute at the National Institutes of Health, working in the area of photodynamic therapy and cytokines for wound healing. After completion of his dermatology residency at Hahnemann University, he accepted a position as Associate Professor in the Department of Dermatology and Cutaneous Biology at Jefferson Medical College. There Dr. Bernstein directed a photobiology laboratory and was the first director of the newly established Laser Surgery Center. Dr. Bernstein’s research focused on the molecular and cellular effects of various lasers on human skin, and on the molecular causes of skin photoaging. This research resulted in the development of a rapid high-throughput screening molecular model of skin photoaging. Dr. Bernstein also earned an M.S.(eng.). in Management of Technology from the School of Engineering and Applied Science at the University of Pennsylvania, where he currently teaches about entrepreneurship and leadership.
Dr. Bernstein founded DakDak Photoaging Technologies and then received a Small Business Innovation Research Award from the National Institutes of Health to further develop this company, based on a molecular model of skin photoaging. Following completion of this grant, Dr. Bernstein sold the company to Charles River Laboratories. Dr. Bernstein is also director of the state-of-the-art Laser Surgery and Cosmetic Dermatology Centers in Ardmore, Pennsylvania and East Hampton, NY, where Dr. Bernstein is often the first in the world to test lasers seeking FDA-clearance. He has well over 30 state-of-the-art devices in his laser center, and continues to produce ground-breaking research.
Dr. Bernstein has served on the scientific advisory board of numerous laser companies, and was on the board of directors of Candela Corporation, a leading manufacturer of medical laser systems, and now heads their Medical Advisory Board. He also serves on the advisory boards of numerous laser, aesthetic and biotechnology companies. Dr. Bernstein has also served as a director for Once Again Me, Inc., and as a director of Intellectual Light, Inc., and founder, president and CEO of Alethia, LLC., as well as serving as Chairman of Freedom-2 Inc. Dr. Bernstein also co-founded American Medical Media, Inc., a web-based company providing information and business services to aesthetic medical practices worldwide, and co-founder of Call Compass, LLC, a CRM software company. Dr. Bernstein has served on the Laser Special Study Section of the National Institutes of Health, and served on the data safety monitoring board for a gene therapy trial. He is past president of the Philadelphia Dermatologic Society, past vice president of the International Society of Cosmetic Laser Surgeons, and has served as Vice President of the American Society for Lasers in Medicine and Surgery.
Dr. Bernstein currently serves as volunteer faculty at the University of Pennsylvania and Temple University in the Department of Dermatology as a Clinical Professor, and has authored over 100 peer-reviewed articles and review articles or book chapters, and given more than 300 presentations at scientific meetings. He has been issued 12 U.S. and numerous international patents. Dr. Bernstein has served as a reviewer for 16 peer-reviewed journals. In addition, Dr. Bernstein has been cited in the popular press appearing on CNN, 20/20, local NBC, CBS and Fox news, and in the Philadelphia Inquirer, the Philadelphia Daily news, Associated Press, Allure, Oprah Magazine, Harpers Bazaar and many other outlets.